As of Q3'25, OPFI reported R&D Expenses of $3.13M and SG&A Expenses of $4.93M, reflecting a slight decrease in R&D spending and a marginal decline in SG&A costs compared to the previous quarter. The latest data point highlights that SG&A remains the larger component of operating expenses. From Q4'22 to Q3'25, both R&D and SG&A expenses have shown moderate fluctuations but no significant long-term growth or decline. R&D Expenses have generally ranged between $2.95M and $3.38M, with occasional minor spikes and dips, while SG&A Expenses have remained higher, fluctuating between $4.22M and $4.95M. Overall, the trend indicates stable operating expense management over the observed period, with SG&A consistently representing the dominant share.